COLUMBUS, Ohio –The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) announces the following awards and more that were recently given to the organization, teams or individuals: Ringel to serve as interim director of Ohio State’s CTSI Dr. Matthew Ringel, professor and director of the Division of Endocrinology, Diabetes and Metabolism at Ohio State, and co-leader of the Cancer Biology Program at the OSUCCC – James, is serving as interim director for Ohio State’s Center for Clinical and Translational Science Institute (CTSI) and as principal investigator (PI) for the NIH Clinical and Translational Science Awards (NIH-CTSA) grant. Ringel, who has been deputy director of the CTSI for the past six years, will continue to champion the work of former CTSI Director Dr. Rebecca Jackson, who died on Oct. 11. As interim director, Ringel will help ensure that translational science at Ohio State and Nationwide Children’s Hospital continues to have resources to support research and innovation. A globally recognized thyroid cancer expert, Ringel holds the Ralph W. Kurtz Chair in Hormonology, serves as co-director of the Center for Cancer Engineering at the OSUCCC – James and is PI for two NCI grant-funded studies focused on translational research for thyroid cancer. Advanced Practice Provider Fellowship Program gains reaccreditation The Advanced Practice Provider (APP) Fellowship Program at Ohio State has received a four-year reaccreditation from the American Nurses Credentialing Center’s (ANCC) Practice Transition Accreditation Program® (PTAP). PTAP is the premier accreditation for fellowship programs that transition advanced practice registered nurses (APRNs) into new practice settings. The James Oncology and Critical Care Advanced Practice Fellowship was previously accredited in 2016 and 2019. In 2019, the university’s APP fellowship programs combined into one Health System Fellowship. With this latest reaccreditation, the university has been accredited as one Health System with the addition of a Primary Care Fellowship. The Ohio State University Health System APP Fellowship is one of only 26 accredited PTAP APRN programs. The APP Fellowship Program is led by Director Kris Mathey, and Primary Care Educator Cheri Bourne. Crawford selected as new leader of Ohio State’s Sickle Cell Program Dr. Regina Crawford, became clinical associate professor and director of the Sickle Cell Program in the Division of Hematology at Ohio State on Jan. 3. In this role, she oversees all clinical and operational aspects of the Sickle Cell Program while maintaining the division’s three-part mission of teaching, research and patient care. Crawford was recruited from Duke University Medical Center, where she was a benign hematologist, therapeutic apheresis specialist and sickle cell specialist who led the Duke Adult Sickle Cell Program for three years. For the past 11 years, she also cared for benign hematology and sickle cell patients at the Durham VA Healthcare System. Crawford earned her MD at the University of Cincinnati, served her internship and residency at the University of Texas Medical Branch in Galveston, and completed her fellowship in Hematology-Oncology at Ohio State in 2007. Noting that there are relatively few physicians around the nation who specialize in treating adult sickle cell patients, Crawford returned to Ohio State because of “the opportunity to focus and build upon the excellent adult sickle cell program here” and hopes to expand the presence of sickle cell specialists statewide. Woyach and Lapalombella land Falk Medical Research Trust Catalyst Award Dr. Jennifer Woyach, and Rosa Lapalombella, are recipients of the Dr. Ralph and Marian Falk Medical Research Trust Catalyst Award for their project titled “Optimizing BTK Inhibitor Therapy in CLL.” This award will provide them with up to $300,000 in seed funding for the next two years for translational research that can be transferred to clinical practice. The award supports development of projects, teams, tools, techniques and management infrastructure necessary to compete for a $1 million Transformational Award for projects that attain the proposed milestones and benchmarks of the Catalyst Award. Woyach and Lapalombella are in the Division of Hematology at Ohio State and members of the OSUCCC – James Leukemia Research Program, co-led by Woyach. Martin earns American Society for Radiation Oncology Fellow designation Dr. Douglas Martin, a radiation oncologist and vice chair of clinical operations for the Department of Radiation Oncology at Ohio State, received the American Society for Radiation Oncology (ASTRO) Fellow designation (FASTRO) at the ASTRO 64th Annual Meeting. The fellows program recognizes individuals who have made substantial contributions to the society and to radiation oncology through research, education, patient care and service. Since its inception in 2006, the FASTRO designation has been awarded to 421 of ASTRO’s 10,000 members worldwide. Much of Martin’s clinical work involves treating patients with genitourinary and gynecologic cancers.   Presley receives WLO Rising Star Award Dr. Carolyn Presley, assistant professor in the Division of Medical Oncology at Ohio State and co-director of the Cancer Aging and Resiliency Clinic at the OSUCCC – James, is the 2022 recipient of the Rising Star Award from Women Leaders in Oncology (WLO), which recognizes and empowers women who have dedicated their careers to advancing oncology research. The Rising Star Award celebrates a physician early in her career who contributes to her field and demonstrates a commitment to transforming the status quo. Presley also is in the Cancer Control Program at the OSUCCC – James, where her research focuses on helping older adults with lung cancer maintain functional independence. These studies incorporate geriatric assessment, palliative care, and supportive-care interventions to improve risk factors for treatment toxicity and functional decline. Lee earns American Urological Association Distinguished Service Award Dr. Cheryl Lee, professor and chair of the Department of Urology at Ohio State and member of the Translational Therapeutics Program at the OSUCCC – James, received a Distinguished Service Award from the American Urological Association (AUA) for her outstanding commitment to patients with bladder cancer and for fostering a culture of inclusivity. The AUA annually honors the contributions of physician researchers and educators to the field of medicine, the specialty of urology and the AUA. Lee, who holds the Dorothy M. Davis Chair in Cancer Research, has focused her entire career on bladder cancer. She has served as principal investigator (PI), co-PI, site PI or co-investigator for more than 75 clinical research trials. Her current research is focused on accruing underrepresented patients to cancer clinical trials. Pollock is chair-elect of Big Ten Cancer Research Consortium Foundation Dr. Raphael E. Pollock, director of the OSUCCC and professor in the Division of Surgical Oncology at Ohio State, is the newly appointed chair-elect of the Big Ten Cancer Research Consortium (CRC) Foundation. A research collaboration among the cancer centers at institutions within the Big Ten Conference, the CRC leverages the scientific and clinical expertise of Big Ten universities to improve the lives of patients with cancer through clinical trials and observational studies. Pollock, who also holds the Kathleen Wellenreiter Klotz Chair in Cancer Research and directs Ohio State’s Sarcoma Research Laboratory, is a surgical oncologist and physician-scientist who specializes in treating patients with soft tissue sarcoma. Voorhees selected as Lymphoma Research Foundation Scholar Dr. Timothy Voorhees, assistant professor in the Division of Hematology at Ohio State, was selected as a Lymphoma Research Foundation Scholar in the 2023 Lymphoma Scientific Research Mentoring Program (LSRMP) – Clinical Track for his project titled “Phase Ib Study to Assess the Safety and Efficacy of Epcoritamab in Relapsed and Refractory PTLD” (post-transplant lymphoproliferative disorder). Voorhees is a hematologist who treats patients with Hodgkin and non-Hodgkin lymphoma. His research focuses on advancing immunotherapy and cellular therapies through clinical trials in hopes that fewer patients will require chemotherapy. The LSRMP is an education and mentoring program with a clinical track and a laboratory/translational track. Jaglowski named associate chief clinical information and cancer informatics officer Dr. Samantha Jaglowski, professor in the Division of Hematology at Ohio State and member of the Leukemia Research Program at the OSUCCC – James, has been named associate chief clinical information and cancer informatics officer (ACCIO/CIO) at the OSUCCC – James. In this newly created role, Jaglowski is responsible for the cancer program’s clinical informatics strategy, integrating with that of the Ohio State Wexner Medical Center and aligning with the other ACCIOs, as well as the chief clinical information officer. Jaglowski has been involved in the OSUCCC – James’ clinical informatics program for many years, serving on committees and leveraging the informatics platforms to improve patient care and facilitate research. To read more about OSUCCC – James awards, honors, accreditations and more, visit cancer.osu.edu. For others news about the OSUCCC – James, visit our News & Media site or read our latest publication. Media Contact: Amanda Harper OSUCCC – James Media Relations Amanda.Harper2@osumc.edu | 614-685-5420